{
  "nctId": "NCT04079881",
  "briefTitle": "Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes",
  "officialTitle": "Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes",
  "protocolDocument": {
    "nctId": "NCT04079881",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-06-25",
    "uploadDate": "2021-07-01T11:03",
    "size": 931217,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04079881/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE1",
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "CROSSOVER",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 1,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-02-13",
    "completionDate": "2020-07-01",
    "primaryCompletionDate": "2020-07-01",
    "firstSubmitDate": "2019-08-29",
    "firstPostDate": "2019-09-06"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* 10 persons with T1D for \\>5 years age \\>18.\n* HbA1c \\<9.5%\n* Patients using either MDI or insulin pumps will be included.\n* Patients using CGM will continue the use during the study, however glucoses will be measured by laboratory methods.\n* Persons of all races, ethnicity and genders will be included\n* Participants should have normal hemoglobin, hematocrit and eGFR \\>60 ml/min/1.73m2.\n\nExclusion Criteria:\n\n* Persons with type 2 diabetes, monogenic diabetes, pancreatic diseases.\n* Pregnancy, prisoners, other vulnerable populations or persons unable to understand the protocol and provide written informed consent.\n* Persons who take daily steroids, any route, for any purpose",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "90 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "AUC Postprandial Glucagon",
        "description": "Glucagon levels done fasting, 30, 60, 120, and 180 minutes",
        "timeFrame": "4 hours"
      }
    ],
    "secondary": [
      {
        "measure": "AUC Postprandial Glucose",
        "description": "* Glucose done fasting, 30, 60, 120, and 180 minutes\n* Glucagon levels done fasting, 30, 60, 120, and 180 minutes\n* Usual insulin dose will be administered 20 minutes before or after the mixed meal challenge with Ensure Plus\\*",
        "timeFrame": "4 hours"
      }
    ],
    "other": []
  },
  "realComplexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 6,
      "exclusionCount": 3,
      "totalCount": 9
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "CROSSOVER"
    },
    "overallComplexityScore": 53,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-21T22:32:39.311Z",
  "dataSource": "ClinicalTrials.gov API v2"
}